Book Reviews | Gordon Campbell | News Flashes | Scoop Features | Scoop Video | Strange & Bizarre | Search

 


Hormone Therapy Makes Comeback--Are Cigarettes Next?

Hormone Therapy Makes Comeback--Are Cigarettes Next?

by Martha Rosenberg
November 9, 2012


Click for big version.

It has been almost ten years since a US government study found that hormone replacement therapy (HRT) did not prevent heart disease and memory loss as advertised but increased the risk of heart attacks by 29 percent and doubled the risk of dementia. Oops.

That was not all the bad news that emerged about HRT. It also increased the risk of breast cancer by 26 percent, stroke by 41 percent, doubled the risk of blood clots and increased the risk of hearing loss, gall bladder disease, urinary incontinence, asthma, the need for joint replacement, melanoma, ovarian, endometrial and lung cancers and non-Hodgkin's lymphoma, according to medical journals.

It was not exactly the fountain of youth it was billed as by hormone drug maker Wyeth (now Pfizer) in high-budget menopause awareness TV ads starring model Lauren Hutton.

In fact, HRT was such a scourge against women, in the first year that millions quit, 2003, the incidence of US breast cancer fell seven percent. It fell 15 percent among women whose tumors were fed by estrogen. Fourteen thousand women who were expected to get breast cancer didn't said news reports. And it wasn't just breast cancer women were spared: heart attack and ovarian cancer rates also fell when women quit HRT, said news reports.

The statistics must have been embarrassing to cancer researchers and public health officials. Not only was a major cause of breast cancer hidden in plain sight, the war on cancer should apparently have been a war on cancer-causing drugs!

It was even more embarrassing because the whole sequence happened before! In 1975, a Food and Drug Administration (FDA) panel found a link between Premarin (a Wyeth HRT drug) and endometrial cancer and when women quit the drug by the millions--the same thing happened. "There was a sharp downward trend in the incidence of endometrial cancer that paralleled a substantial reduction in prescriptions for replacement estrogens," reported the New England Journal of Medicine (NEJM) in 1979.

Not wanting to lose its billion dollar HRT franchise, Wyeth's medical director wrote doctors at the time that HRT still had "proven benefits" at the "the lowest maintenance dose" and that it was "simplistic indeed to attribute an apparent increase in the diagnosis of endometrial carcinoma solely to estrogen therapy."

Thirty years later, when cancer rates again dropped, Wyeth also bit back. It announced the reason women weren't seeing prevention of heart disease and memory loss from HRT was they weren't taking it soon enough. They needed to start treatment sooner. Ka-ching. The early treatment campaign was called the "timing theory."

Soon a National Institute on Aging trial and privately funded trials on "menopausal" primates, both led by Wyeth-funded investigators, were underway at major medical centers. After all, before 2002, millions of American women, perhaps the majority, had been on HRT. Wasn't there a way to get them back?

Last month the hormone revival campaign hit pay dirt. Women "who took treatments such as Pfizer Inc.'s estrogen pill Premarin within five years of menopause lowered their chance of Alzheimers by 30 percent," wrote the Washington Post about a study in the journal Neurology.

"It's really important to distinguish between studies that are able to look at early use of hormone therapy versus later use," said Pauline M. Maki, PhD on WebMD about the same study. Maki has received research support from Wyeth according to a July 2010 article in the journal Menopause. WebMD just imported a new CEO from Pfizer.

The study was funded by the National Institute on Aging (NIA) not Big Pharma. But NIA is so collegial with hormone makers, it funded the North American Menopause Society's entire 2009 annual meeting replete with Wyeth-funded doctor presenters and even Wyeth employee presenters. It also invited top Wyeth officials for a "Where Are We Now?" meeting soon after its products were linked to cancer/heart disease/blood clots/stroke/dementia.

Even if HRT did lower Alzheimer risk--would it be ethical to prescribe it in light of its other risks or even conduct trials? HRT's negative cognitive effects are so well known, a 2006 Reuters story began, "Regular exercise may prevent the mental decline associated with the long-term use of hormone replacement therapy (HRT)." And two studies in the January 13, 2009 issue of Neurology link HRT to brain shrinkage.

Hormone markers have also floated the idea that early HRT would prevent heart disease and/or cancer. But a 2011 analysis from the Million Women Study, sponsored by England's National Health Service, found women who took hormones the earliest, before or soon after the onset of menopause, were at the greatest risk of getting breast cancer.

Why does the government let--and even help--Big Pharma market HRT like it's a brand new product instead of the cause of two cancer epidemics--so far? Would anyone tell cigarette smokers to start smoking earlier?

*************

The complete story of unethical marketing of HRT to women is found in Martha Rosenberg's recent book, Born with a Junk Food Deficiency.

© Scoop Media

 
 
 
 
 
Top Scoops Headlines

 

Syed Atiq ul Hassan: Eye-Opener For Islamic Community

An event of siege, terror and killing carried out by Haron Monis in the heart of Sydney business district has been an eye-opener for the Islamic Community in Australia. Haron was shot down before he killed two innocent people, a lawyer and a manager ... More>>

Jonathan Cook: US Feels The Heat On Palestine Vote At UN

The floodgates have begun to open across Europe on recognition of Palestinian statehood. On 12 December the Portuguese parliament became the latest European legislature to call on its government to back statehood, joining Sweden, Britain, Ireland, France ... More>>

ALSO:


Fightback: MANA Movement Regroups, Call For Mana Wahine Policy

In the wake of this years’ electoral defeat, the MANA Movement is regrouping. On November 29th, Fightback members attended a Members’ Hui in Tāmaki/Auckland, with around 70 attending from around the country. More>>

Ramzy Baroud: The Mockingjay Of Palestine: “If We Burn, You Burn With Us”

Raed Mu’anis was my best friend. The small scar on top of his left eyebrow was my doing at the age of five. I urged him to quit hanging on a rope where my mother was drying our laundry. He wouldn’t listen, so I threw a rock at him. More>>

ALSO:

Don Franks: Future Of Work Commission: Labour's Shrewd Move

Lunging boldly towards John Key, shouting 'Cut the crap!' - Andrew Little was great, wasn't he? Labour's new leader spoke for many people fed up with Key's flippant arrogant deceit. Andrew Little nailing the Prime minister on lying about contacting a rightwing ... More>>

Asia-Pacific Journal: MSG Headache, West Papuan Heartache? Indonesia’s Melanesian Foray

Asia and the Pacific--these two geographic, political and cultural regions encompass entire life-worlds, cosmologies and cultures. Yet Indonesia’s recent enthusiastic outreach to Melanesia indicates an attempt to bridge both the constructed and actual ... More>>

Valerie Morse: The Security State: We Should Not Be Surprised, But We Should Be Worried

On the very day that the Inspector-General of Intelligence and Security released her report into the actions of people the Prime Minister’s office in leaking classified Security Intelligence Service (NZSIS) documents to right-wing smearmonger Cameron ... More>>

Ramzy Baroud: PFLP Soul-Searching: Rise And Fall Of Palestine’s Socialists

When news reports alleged that the two cousins behind the Jerusalem synagogue attack on 18 November were affiliated with the Popular Front for the Liberation of Palestine, a level of confusion reigned. Why the PFLP? Why now? More>>

Get More From Scoop

 
 
 
 
 
 
 
Top Scoops
Search Scoop  
 
 
Powered by Vodafone
NZ independent news